IO Biotech, Inc. (IOBTQ) Profit After Tax (2020 - 2025)

IO Biotech (IOBTQ) has 6 years of Profit After Tax data on file, last reported at -$8.4 million in Q3 2025.

• Quarterly Profit After Tax rose 65.11% year-over-year to -$8.4 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$88.4 million (up 2.19% YoY) and the FY2024 annual result came in at -$95.5 million, down 10.94% from the prior year.
• Profit After Tax advanced to -$8.4 million in Q3 2025, from -$26.2 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of -$3.7 million in Q1 2021 to a low of -$38.4 million in Q2 2021.
• A 5-year average of -$19.9 million and a median of -$20.7 million in 2024 frame the typical range for Profit After Tax.
• Annual changes were most pronounced in 2021 — Profit After Tax plunged 748.29% — and 2025, when it surged 65.11%.
• Tracing IOBTQ's Profit After Tax over 5 years: stood at -$21.3 million in 2021, then rose by 5.61% to -$20.1 million in 2022, then sank by 30.17% to -$26.2 million in 2023, then declined by 19.71% to -$31.3 million in 2024, then surged by 73.27% to -$8.4 million in 2025.
• The last three Profit After Tax figures came in at -$8.4 million (Q3 2025), -$26.2 million (Q2 2025), and -$22.4 million (Q1 2025), per Business Quant data.